Answers are grounded in this paper and cite their sources.
Organic emitters with both thermally activated delayed fluorescence (TADF) and room-temperature phosphorescence (RTP) have attracted widespread interest for their intriguing luminescent properties. Herein, a series of triphenylamine-substituted isoquinoline derivatives possessing monomeric TADF and aggregated RTP properties are reported. As the molecules exhibited various forms of π-π and charge transfer (CT) stacking with different intensities, inter/intramolecular CT can be meticulously modulated to achieve tunable TADF-RTP. Aggregated phosphorescence originates from intermolecular CT initiated by CT dimers, whereas monomeric TADF is facilitated by intramolecular CT enhanced by π-π dimers. Leveraging the properties of these molecules, luminescent materials with tunable TADF-RTP properties in multistates are obtained by molecular substitution position alignment, dealing with different solvents, grinding, adjusting concentration, changing polymer matrix, photoactivation, and heat treatment. This work is critical for a deeper understanding of construction and regulation of the TADF-RTP dual-channel emission, enabling the development of advanced optoelectronic devices with tailored emission properties.
No takes yet. Share an insight, caveat, or question.
He et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: